RP 48497

CAS No. 148891-53-6

RP 48497( —— )

Catalog No. M26580 CAS No. 148891-53-6

RP 48497 is a photodegradation product of Eszopiclone. Eszopiclone is used in the treatment of insomnia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 307 Get Quote
10MG 463 Get Quote
25MG 838 Get Quote
50MG 1257 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    RP 48497
  • Note
    Research use only, not for human use.
  • Brief Description
    RP 48497 is a photodegradation product of Eszopiclone. Eszopiclone is used in the treatment of insomnia.
  • Description
    RP 48497 is a photodegradation product of Eszopiclone. Eszopiclone is used in the treatment of insomnia.(In Vitro):RP 48497 is a non-chiral potential photodegradation product.RP 48497 formation is caused by bright light.
  • In Vitro
    RP 48497 is a non-chiral potential photodegradation product whose formation is caused by bright light.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    DNV| HCV| influenza virus| RSV
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    148891-53-6
  • Formula Weight
    246.65
  • Molecular Formula
    C11H7ClN4O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Clc1ccc(nc1)N1Cc2nccnc2C1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bedard KM, et al. Isoflavone agonists of IRF-3 dependent signaling have antiviral activity against RNA viruses. J Virol. 2012 Jul;86(13):7334-44.
molnova catalog
related products
  • GSK2807 Trifluoroace...

    GSK2807 Trifluoroacetate is a selective and SAM-competitive inhibitor of SMYD3 (Ki: 14 nM; IC50: 130 nM).GSK2807, a potent and selective, SAM-competitive inhibitor of SMYD3 (Ki = 14 nM).?A high-resolution crystal structure reveals that GSK2807 bridges the gap between the SAM-binding pocket and the substrate lysine tunnel of SMYD3.

  • Bemnifosbuvir hemisu...

    Bemnifosbuvir hemisulfate is a potent inhibitor of HCV virus replication.

  • Cinobufotenine

    Cinobufotenine is a parasympathetic ganglia stimulant and is competitively antagonized by hexamethonium.